IDH2 and acute myeloid leukemia: These data together seemed to suggest an active reductive (reverse) TCA cycle in AML cells was highly active to convert α-KG to isocitrate/citrate, and a suppression of IDH2 by shRNA would lead to an accumulation of α-KG and a decrease of isocitrate and citrate, as illustrated in Fig. 3g.